Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 147.54M P/E 50.50 EPS this Y - Ern Qtrly Grth -44.90%
Income -607.02k Forward P/E 25.25 EPS next Y 33.30% 50D Avg Chg -9.00%
Sales 67.23M PEG - EPS past 5Y - 200D Avg Chg -13.00%
Dividend N/A Price/Book 2.54 EPS next 5Y - 52W High Chg -23.00%
Recommedations 2.00 Quick Ratio 1.06 Shares Outstanding 152.76M 52W Low Chg 1.00%
Insider Own 27.75% ROA 0.46% Shares Float 128.09M Beta 0.29
Inst Own 19.48% ROE -1.00% Shares Shorted/Prior -/- Price 1.01
Gross Margin 50.35% Profit Margin -0.90% Avg. Volume 2,024 Target Price -
Oper. Margin -1.32% Earnings Date May 13 Volume 14,650 Change -4.17%
About HAMILTON THORNE LTD

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, the company manufactures and distributes medical products for reproductive medicine; manufactures bespoke workstations, incubators, and equipment for IVF laboratories; researches, designs, develops, sells, installs, and services in-vitro diagnostic systems; and manufactures ovum pickup needles, catheters, and other devices. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as capital equipment and consumables, software, and other services. It sells its products and services under Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech brand names through a direct sales force in the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 100 countries. Hamilton Thorne Ltd. is headquartered in Beverly, Massachusetts.

HAMILTON THORNE LTD News
04/26/24 Hamilton Thorne Ltd.'s (TSE:HTL) largest shareholders are retail investors with 51% ownership, institutions own 33%
04/10/24 Hamilton Thorne Ltd. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
03/27/24 Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023
03/21/24 Hamilton Thorne to Announce Q4 and Full Year 2023 Financial Results and Hold Conference Call on March 27, 2024
01/22/24 Hamilton Thorne (TSE:HTL) Could Be Struggling To Allocate Capital
12/21/23 Hamilton Thorne Appoints Dr. Ekaterina (Kate) Torchilin as President and CEO
12/17/23 Are Investors Undervaluing Hamilton Thorne Ltd. (TSE:HTL) By 40%?
11/26/23 Hamilton Thorne's (TSE:HTL) investors will be pleased with their favorable 32% return over the last five years
11/13/23 Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2023
11/07/23 Hamilton Thorne to Announce Q3 2023 Financial Results and Hold Conference Call on November 13, 2023
10/16/23 RETRANSMISSION: Lytham Partners Announces KOL Panels and Participating Companies for its Fall 2023 Investor Conference
10/10/23 Hamilton Thorne Announces the Acquisition of Gynetics Medical Products N.V.
09/21/23 Hamilton Thorne Ltd. Opens the Market
09/06/23 Hamilton Thorne Graduating to Toronto Stock Exchange Main Board
08/21/23 TSX Venture Exchange, Hamilton Thorne Ltd., View From The C-Suite
08/17/23 Hamilton Thorne Reports Revenue For The Quarter And Six Months Ended June 30, 2023
08/15/23 Investors Could Be Concerned With Hamilton Thorne's (CVE:HTL) Returns On Capital
08/10/23 Hamilton Thorne to Announce Q2 2023 Financial Results and Hold Conference Call on August 17, 2023
07/26/23 Does The Market Have A Low Tolerance For Hamilton Thorne Ltd.'s (CVE:HTL) Mixed Fundamentals?
05/15/23 Hamilton Thorne Reports Record Revenue for the Quarter Ended March 31, 2023